Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Using a speaking valve and transtracheal end‑expiratory pressure to predict upper airway openness

Official title: Speaking Valves With Transtracheal End-expiratory Pressure Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients: A Multicenter, Prospective Study

Run by Capital Medical University · NCT07107243 · Data updated 2026-11-12

This trial tests whether using a speaking valve together with a transtracheal end‑expiratory pressure (TTPEE) measurement can tell if the upper airway is open in people with prolonged tracheostomies.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorCapital Medical University
Academic / other
Locations5 sites (Hunan, Hunan and 4 other locations)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedSeptember 30, 2026
Study endsOctober 31, 2026
Registry record updatedJanuary 21, 2026
Trial IDNCT07107243 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are prolonged tracheostomy patients who have been off the ventilator for more than 48 hours, are stable without sepsis or organ failure, have PCO2 <60 mmHg, and can tolerate cuff deflation.

Probably not a fit

Patients with known severe upper airway obstruction, inability to tolerate cuff deflation, laryngopharyngeal trauma, active sepsis or major organ failure, or those whose airway has already been assessed by endoscopy are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter interventional trial applies a bedside, noninvasive method combining a speaking valve (SV) with transtracheal end‑expiratory pressure (TTPEE) measurement to predict upper airway patency in prolonged tracheostomy patients. Eligible participants are those weaned from the ventilator for more than 48 hours, hemodynamically stable, without sepsis or organ failure, and with PCO2 below 60 mmHg; bronchoscopy may be used as a comparator when clinically indicated. The protocol excludes patients with known severe upper airway obstruction, laryngopharyngeal trauma, inability to tolerate cuff deflation, or prior endoscopic airway assessment. Data will be collected at three Chinese rehabilitation hospitals to determine feasibility and diagnostic accuracy for guiding decannulation decisions.

Why it matters

Potential benefit: If successful, this method could provide a simple bedside test to help identify patients who can safely have their tracheostomy decannulated.

How similar studies have gone: Speaking valves and pressure measurements have been used previously to infer airway patency, but combining SV with transtracheal end‑expiratory pressure measurement is relatively novel and not yet widely validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Weaned from ventilator more than 48 hours
* No any organ failure
* No sepsis
* Stable heart rate and blood pressure
* Lung infection under control
* PCO2\<60mmHg
* Patient and family sign informed consent form

Exclusion Criteria:

* Serious dysfunction of vital organs
* Inability to tolerate cuff deflation
* Laryngopharyngeal trauma
* Known severe upper airway obstruction before referrer to our department
* Endoscopy(bronchoscopy or laryngoscopy) has been performed and the condition of the upper airway has known

Where it's running

  • Hunan Rehabilitation Hospital
    Hunan, Hunan, China
    Recruiting
  • Jiangbin Hospital of Guangxi Zhuang Autonomous Region
    Guangxi, Jiangbin, China
    Recruiting
  • Beijing Rehabilitation Hospital of Capital Medical University
    Beijing, Shijingshan, China
    Recruiting
  • YanBian University Hospital
    Jilin City, Yanbian, China
    Recruiting
  • Zhengzhou Central Hospital Affiliated to Zhengzhou University
    Henan, Zhengzhou, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.